Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Manol Jovani

Gastroenterology Miami, FL Medical Doctor

NPI 1144794496 CMS profile 9312479

8950 N Kendall Dr Ste 306W, Miami, FL 33176

Open in the dashboard

General payments

$19,165

62 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Manol Jovani of Miami, FL is reported in the CMS Open Payments database as having received $19,165 across 62 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,090 14
2024 General $15,680 22
2023 General $690 7
2022 General $1,647 17
2021 General $57 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Manol Jovani
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Manol Jovani were reported at $1,090. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Manol Jovani Gastroenterology median Middle half National median
2019 $0 $417 $126–$1,100 $163
2020 $0 $224 $74–$624 $114
2021 $57 $352 $106–$1,054 $132
2022 $1,647 $448 $129–$1,270 $149
2023 $690 $533 $150–$1,390 $160
2024 $15,680 $605 $160–$1,606 $164
2025 $1,090 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. PENTAX of America, Inc. $15,507 19 payments
  2. Olympus Corporation of the Americas $1,647 17 payments
  3. Boston Scientific Corporation $708 10 payments
  4. Medtronic, Inc. $368 4 payments
  5. Creo Medical Inc. $337 1 payment
  6. AbbVie, Inc. $158 3 payments
  7. Olympus America Inc. $135 2 payments
  8. Intra-Sana Laboratories $105 2 payments
  9. FUJIFILM Medical Systems USA, Inc. $85 1 payment
  10. Cook Medical LLC $73 1 payment
  11. Other $41 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $10,560 26 payments
  2. Consulting Fee $6,500 2 payments
  3. Food and Beverage $2,092 33 payments
  4. Entertainment $13 1 payment
Products named General payments · program years 2021–2025
  1. Single Use Electrosurgical Knife KD-655 $1,652 18 payments
  2. Single Use Electrosurgical Hemostatic Forceps $1,264 16 payments
  3. Olympus $384 1 payment
  4. DISPOSABLE DISTAL ATTACHMENT $384 1 payment
  5. VISIGLIDE $384 1 payment
  6. SPEEDBOAT $337 1 payment
  7. DRAGONFLY PANCREATICOBILIARY SCOPE AND INSTRUMENT CHANNEL CAPS $209 2 payments
  8. SpyGlass $165 1 payment
  9. APOLLO ESG System $150 1 payment
  10. EVIS EXERA III VIDEO SYSTEM CENTER $131 1 payment
  11. Other $1,545 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

22

Median for Gastroenterology: 569

Drug cost

$373

Median for Gastroenterology: $104,976

Branded share of claims

0%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dicyclomine Hcl Generic 11 $220
Pantoprazole Sodium Generic 11 $153

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$86,727

Medicare's payments for the services billed

Medicare patients

228

Average age 77

Services billed

673

121 women, 107 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 72%
Arthritis 60%
Ischemic heart disease 57%
Heart failure 40%
Chronic kidney disease 37%
Depression 33%
Alzheimer's or dementia 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

62 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record